Market Research Logo

Alzheimer’s Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Alzheimer’s Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global Alzheimer’s drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global Alzheimer’s drugs market to grow with a CAGR of 7.0% over the forecast period of 2018-2024. The study on Alzheimer’s drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The rising occurrence of neurodegenerative diseases among the elderly and a healthy support from governments across developed countries has led to the development of new drugs and therapies which has helped in the development and growth of the Alzheimer's drugs market .Additionally lack of Duchenne muscular dystrophy (DMD) is another factor that promotes the growth of the market. The lack of DMDs extends the treatment schedule for Alzheimer's disease, which in turn, increases the healthcare costs for patients.

Among the region North America is expected to the largest market for Alzheimer’s drugs. The large number of patients suffering from the Alzheimer’s disease, high purchasing power for expensive drugs and compensation policies for the treatment of this disease is likely to boost the growth in this market. The increasing awareness about neurodegenerative diseases in Asia Pacific region will boost the growth of the global Alzheimer's drugs market in the next coming years.

The report on Alzheimer’s drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global Alzheimer’s drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Alzheimer’s drugs market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global Alzheimer’s drugs market is segmented on the basis of drug class and distribution channel.

Global Alzheimer’s Drugs Market by Drug Class
Cholinergic
Memantine
Combined Drug
Others
Global Alzheimer’s Drugs Market by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Company Profiles
H Lundbeck A/S
Eisai Co Ltd
Ono Pharmaceutical
Daiichi Sankyo Company Limited
Johnson & Johnson
Merz Holding GmbH & Co KG
Others

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of Alzheimer’s drugs market.
2. Complete coverage of all the segments in Alzheimer’s drugs market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global Alzheimer’s drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on Alzheimer’s drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global Alzheimer’s drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Company Profiles
H Lundbeck A/S
Eisai Co Ltd
Ono Pharmaceutical
Daiichi Sankyo Company Limited
Johnson & Johnson
Merz Holding GmbH & Co KG
Others

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report